NCT00499616 Combination Chemotherapy and Surgery With or Without Isotretinoin in Treating Young Patients With Neuroblastoma Status COMPLETED Phase PHASE3
NCT00490529 Phase 1-2 of a CpG-Activated Whole Cell Vaccine Followed by Autologous Immunotransplant for MCL Status COMPLETED Phase PHASE2
NCT00482053 Phase 2 Poor Risk DLBCL of TLI and ATG Followed by Matched Allogeneic HT as Consolidation to Autologous HCT Status TERMINATED Phase PHASE2
NCT00481832 Autologous Followed by Non-myeloablative Allogeneic Transplantation for Non-Hodgkin's Lymphoma Status TERMINATED Phase PHASE2
NCT00477971 Low-Dose Melphalan and Dexamethasone Compared With High-Dose Melphalan Followed By Autologous Stem Cell Transplant in Treating Patients With Primary Systemic Amyloidosis Status COMPLETED Phase PHASE3
NCT00469014 Busulfan, Fludarabine, Clofarabine With Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia Status COMPLETED Phase PHASE2
NCT00467051 Combination Chemotherapy in Treating Young Patients With Recurrent or Resistant Malignant Germ Cell Tumors Status COMPLETED Phase PHASE2
NCT00462787 Combination Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Leukemia Status COMPLETED Phase PHASE1
NCT00450827 Iodine I 131 Monoclonal Antibody 3F8 and Bevacizumab in Treating Patients With Relapsed or Refractory Neuroblastoma Status COMPLETED Phase PHASE1
NCT00450450 Donor Bone Marrow Transplant With or Without G-CSF in Treating Young Patients With Hematologic Cancer or Other Diseases Status COMPLETED Phase PHASE3
NCT00439556 Bortezomib and Chemotherapy in Treating Participants With Lymphoid Malignancies Undergoing Stem Cell Transplant Status COMPLETED Phase PHASE2
NCT00438958 Sibling Donor Peripheral Stem Cell Transplant or Sibling Donor Bone Marrow Transplant in Treating Patients With Hematologic Cancers or Other Diseases Status COMPLETED Phase PHASE3
NCT00433537 Combination Chemotherapy and Rituximab in Treating Patients With Untreated Mantle Cell Lymphoma Status COMPLETED Phase PHASE2
NCT00432094 Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors Status COMPLETED Phase PHASE2
NCT00425802 Chemotherapy, Total-Body Irradiation, Rituximab, and Donor Stem Cell Transplant in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia Status COMPLETED Phase PHASE2
NCT00423852 Paclitaxel, Ifosfamide, and Carboplatin Followed By Autologous Stem Cell Transplant in Treating Patients With Germ Cell Tumors That Did Not Respond to Cisplatin Status COMPLETED Phase PHASE1/PHASE2
NCT00423514 Clofarabine, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk and/or Advanced Hematologic Cancer or Other Disease Status COMPLETED Phase PHASE1/PHASE2
NCT00417053 Combination Chemotherapy in Treating Infants With Newly Diagnosed Neuroblastoma Who Are Undergoing Surgery With or Without Autologous Bone Marrow or Peripheral Stem Cell Transplant Status UNKNOWN Phase PHASE3
NCT00416910 Combination Chemotherapy With or Without G-CSF in Treating Patients With Relapsed Chronic Lymphocytic Leukemia Status TERMINATED Phase PHASE3